Komal Jhaveri, Memorial Sloan Kettering Cancer Center (IMAGE)

ECOG-ACRIN Cancer Research Group

Komal Jhaveri, Memorial Sloan Kettering Cancer Center

Caption

Dr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment arm that found new data on treatment with ado-trastuzumab (T-DM1) in patients with salivary gland cancer, a rare disease.

Credit

Supplied by Memorial Sloan Kettering Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.